Supplementary Table 1 from RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J. Compadre, Mary M. Mullen|Unknown|2023Cited by 0
Supplementary Table 1 from RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J. Compadre, Mary M. Mullen|Unknown|2023Cited by 0
Supplementary Table 1 from RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J. Compadre, Mary M. Mullen|Unknown|2023Cited by 0
Supplementary Table 1 from RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J. Compadre, Mary M. Mullen|Unknown|2023Cited by 0
Supplementary Table 1 from RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J. Compadre, Mary M. Mullen|Unknown|2025Cited by 0